MS
A raise that still sounds cautious
Morgan Stanley just did the analyst version of saying, “You can go, but don’t get too excited.” It kept its Equal-Weight rating on Morgan Stanley (MS) and bumped the price target to $200 from $189. That’s a modest upgrade, not a victory lap.
What that means for your portfolio
Equal-Weight is Wall Street speak for “we think it should roughly keep pace with the market.” So even with the higher target, the message isn’t exactly fireworks. It’s more like: there’s some upside here, but don’t expect the stock to sprint out of the gate in a cape.
A few extra details are worth keeping in your mental filing cabinet:
- The stock was trading at $191.62 in the source material, already close to the new target.
- GuruFocus flagged MS as 38.3% above its GF Value estimate.
- The stock’s TTM P/E of 18.77 sits above its 5-year median of 15.06.
Why investors may still stay cautious
The article also points to $25.2 million in insider selling over the last three months. That doesn’t automatically mean doom, but it’s not the kind of thing that makes investors cheer into their coffee.
So the setup is a little mixed: analysts are willing to lift the target, but valuation screens still say the stock looks expensive, and insider activity adds a dash of “maybe pump the brakes.”
Big picture: this is a small bullish adjustment, not a thesis rewrite. For MS holders, it’s a reminder that even when Wall Street likes a name, it doesn’t always mean it thinks the shares are cheap.